Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 20 days ( 0 % )
Last Price $0.255 0 %
High/ Low $0.255 - $0.255 0%
Chg 7 Days N/A $0.255 $0.255
Chg 30 Days N/A $0.255 $0.255
Chg 12 mos -96.94 % $8.32 $0.255
Trend - 3 mos -8.20 % Width: 49.92 %
Trend - 12 mos -89.06 % Width: 134.13 %
Pred. range - 3 mos $0.184 - $0.276 -27.79 % - 8.26 %
Pred. range - 12 mos N/A - $0.129 -100.00 % - -49.27 %
Short MA avg 3 mos Buy Jul 11, 2019 - 48 days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Buy Jul 18, 2019 - 43 days
Long MA avg 12 mos Buy Mar 11, 2019 - 133 days
Short/Long MA avg 12 mos Sell Mar 14, 2019 - 130 days
Pivot Short Buy Jul 03, 2019 - 53 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Insys Therapeutics

Insys Therapeutics Insys Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes supportive care products. The company markets Subsys, a sublingual fentanyl spray for breakthrough cancer pain in opioid-tolerant cancer patients in the United States. Its lead product candidate is Syndros, an orally administered liquid formulation of dronabinol. The company is also developing Cannabidiol Oral Solution, a synthetic cannabidiol for childhood ... INSY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT